LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer
Abstract RNA-based therapeutics highlighted novel approaches to target either coding or noncoding molecules for multiple diseases treatment. In breast cancer (BC), a multitude of deregulated long noncoding RNAs (lncRNAs) have been identified as potential therapeutic targets also in the context of an...
Saved in:
Main Authors: | Viola Melone, Domenico Palumbo, Luigi Palo, Noemi Brusco, Annamaria Salvati, Antonietta Tarallo, Giorgio Giurato, Francesca Rizzo, Giovanni Nassa, Alessandro Weisz, Roberta Tarallo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-025-07423-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
17β-estradiol and estrogen receptor alpha protect mouse ovarian follicle development by repressing atresia
by: Eri Ueno, et al.
Published: (2025-02-01) -
Overcoming breast cancer cell treatment resistance by optimizing sonodynamic therapy and radiation sensitizers on lncRNA PVT1 and miR-1204 expression
by: Ali Neshastehriz, et al.
Published: (2025-02-01) -
LncRNA-PVT1 enhances glucose metabolism of pediatric low-grade glioma cells through sponging miR-187-3p
by: Beibei Li, et al.
Published: (2024-12-01) -
NFIB-Mediated lncRNA PVT1 Aggravates Laryngeal Squamous Cell Carcinoma Progression via the miR-1301-3p/MBNL1 Axis
by: Tian Tang, et al.
Published: (2021-01-01) -
Comparison of Electrical and Thermal Performances of Glazed and Unglazed PVT Collectors
by: Jin-Hee Kim, et al.
Published: (2012-01-01)